Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beer

Showing results (201-210 of 265) with videos related to

Pageof 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2014
Comparison of the transcriptional landscapes between human and mouse tissuesShin Lin, Yiing Lin, Joseph R Nery, et al.
Blood|December 10, 2020
MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulusElizabeth Bulaeva, Davide Pellacani, Naoto Nakamichi, et al.
JACC. Clinical Electrophysiology|September 16, 2023
His-Purkinje Conduction System Pacing Optimized Trial of Cardiac Resynchronization Therapy vs Biventricular Pacing: HOT-CRT Clinical TrialPugazhendhi Vijayaraman, Parash Pokharel, Faiz A Subzposh, et al.
Molecular Cell|June 2, 2007
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosisTsung-Cheng Chang, Erik A Wentzel, Oliver A Kent, et al.
Blood|October 24, 2014
Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13Suzan Imren, Michael Heuser, Maura Gasparetto, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Reprogramming of neuronal genome function and phenotype by astrocytesBoxun Li, Kevin T Hagy, Alexias Safi, et al.
Science Translational Medicine|June 21, 2019
Epigenetic activation and memory at a <i>TGFB2</i> enhancer in systemic sclerosisJoseph Yusup Shin, James Daniel Beckett, Rustam Bagirzadeh, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
Nature Cell Biology|July 2, 2013
The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cellsMichael R Copley, Sonja Babovic, Claudia Benz, et al.
Pageof 27

Showing results (201-210 of 265) with videos related to

Sort By:
Pageof 27
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2014
Comparison of the transcriptional landscapes between human and mouse tissuesShin Lin, Yiing Lin, Joseph R Nery, et al.
Blood|December 10, 2020
MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulusElizabeth Bulaeva, Davide Pellacani, Naoto Nakamichi, et al.
JACC. Clinical Electrophysiology|September 16, 2023
His-Purkinje Conduction System Pacing Optimized Trial of Cardiac Resynchronization Therapy vs Biventricular Pacing: HOT-CRT Clinical TrialPugazhendhi Vijayaraman, Parash Pokharel, Faiz A Subzposh, et al.
Molecular Cell|June 2, 2007
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosisTsung-Cheng Chang, Erik A Wentzel, Oliver A Kent, et al.
Blood|October 24, 2014
Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13Suzan Imren, Michael Heuser, Maura Gasparetto, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Reprogramming of neuronal genome function and phenotype by astrocytesBoxun Li, Kevin T Hagy, Alexias Safi, et al.
Science Translational Medicine|June 21, 2019
Epigenetic activation and memory at a <i>TGFB2</i> enhancer in systemic sclerosisJoseph Yusup Shin, James Daniel Beckett, Rustam Bagirzadeh, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
Nature Cell Biology|July 2, 2013
The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cellsMichael R Copley, Sonja Babovic, Claudia Benz, et al.
Pageof 27